期刊
FRONTIERS IN PLANT SCIENCE
卷 10, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fpls.2019.00455
关键词
virus-like particles; epitope display; hepatitis B core antigen; dengue envelope glycoprotein; envelope glycoprotein domain III; dengue vaccine; tandem core technology
资金
- John Innes Centre, United Kingdom
- University of Nottingham Malaysia, Malaysia
- iQur Limited, United Kingdom
- United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L020955/1]
- Institute Strategic Programme Grant, Understanding and Exploiting Plant and Microbial Secondary Metabolism [BB/J004596/1]
- Institute Strategic Programme Grant, Molecules from Nature - Enhanced Research Capacity [BBS/E/J/000PR9794]
- John Innes Foundation
- BBSRC [BBS/E/J/000PR9794, BB/L020955/1] Funding Source: UKRI
Dengue fever is currently ranked as the top emerging tropical disease, driven by increased global travel, urbanization, and poor hygiene conditions as well as global warming effects which facilitate the spread of Aedes mosquitoes beyond their current distribution. Today, more than 100 countries are affected most of which are tropical Asian and Latin American nations with limited access to medical care. Hence, the development of a dengue vaccine that is dually cost-effective and able to confer a comprehensive protection is ultimately needed. In this study, a consensus sequence of the antigenic dengue viral glycoprotein domain III (cEDIII) was used aiming to provide comprehensive coverage against all four circulating dengue viral serotypes and potential Glade replacement event. Utilizing hepatitis B tandem core technology, the cEDIII sequence was inserted into the immunodominant c/e1 loop region so that it could be displayed on the spike structures of assembled particles. The tandem core particles displaying cEDIII epitopes (tHBcAg-cEDIII) were successfully produced in Nicotiana benthamiana via Agrobacterium-mediated transient expression strategy to give a protein of similar to 54 kDa, detected in both soluble and insoluble fractions of plant extracts. The assembled tHBcAg-cEDIII virus-like particles (VLPs) were also visualized from transmission electron microscopy. These VLPs had diameters that range from 32 to 35 nm, presenting an apparent size increment as compared to tHBcAg control particles without cEDIII display (namely tEL). Mice immunized with tHBcAg-cEDIII VLPs showed a positive seroconversion to cEDIII antigen, thereby signifying that the assembled tHBcAg-cEDIII VLPs have successfully displayed cEDIII antigen to the immune system. If it is proven to be successful, tHBcAg-cEDIII has the potential to be developed as a cost-effective vaccine candidate that confers a simultaneous protection against all four infecting dengue viral serotypes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据